Obesity

Latest News

New Phase 3 Trials Investigate Survodutide as a Promising Treatment for Obesity / Image credit: ©missbobbit/AdobeStock
New Phase 3 Trials Investigate Survodutide as a Promising Treatment for Obesity

November 6th 2024

SYNCHRONIZE-1 and -2 will provide "robust evidence" on the safety, efficacy, and tolerability of survodutide in adults with obesity with or without T2D.

Semaglutide 2.4 mg Reduces Risk for Hospitalization for Any Cause in Adults with CVD, Obesity / image credit Steven J Nicholls, MBBS, PhD, Monash University Melbourne, Australia
Semaglutide 2.4 mg Reduces Risk for Hospitalization for Any Cause in Adults with CVD, Obesity

November 5th 2024

ObesityWeek 2024: Viking Therapeutics Presents New Positive Data from VK2735 Obesity Program
ObesityWeek 2024: Viking Therapeutics Presents New Positive Data from VK2735 Obesity Program

November 4th 2024

Metabolic Bariatric Surgery Takes a Backseat as GLP-1RA Use Soars / Semaglutide, liraglutide injections / Image credit: ©silukstockimages/AdobeStock
Metabolic Bariatric Surgery Takes a Backseat as GLP-1RA Use Soars, According to New Research

November 4th 2024

GLP-1RAs Reduce the Risk of Early-Onset Colorectal Cancer in Adults with T2D / Image credit: American College of Gastroenterology (ACG)
GLP-1RAs Reduce the Risk of Early-Onset Colorectal Cancer in Adults with T2D

October 31st 2024

More News

© 2024 MJH Life Sciences

All rights reserved.